Oura Agrees to Acquire AI-Native Care Startup Counsel Health
Oura is expanding its clinical capabilities through a 625 million dollar agreement to acquire Counsel Health, as reported by The Verge. This acquisition follows a successful integration of Counsel Health's AI chatbot into the Oura app earlier this year, signaling a deeper move by the wearable manufacturer into personalized medical services and physician-led care.
Context from Industry Pulse
The acquisition of Counsel Health places Oura at the intersection of consumer technology and clinical services. By integrating a startup that employs 70 staff members and a network of 50 physicians, Oura is moving beyond traditional hardware sales into a service-oriented model. This transition reflects a broader trend among major tech players, such as Google and Anthropic, who are currently launching specialized tools like the Pixel Tag or Claude Meetings to deepen user engagement. Oura's focus on reproductive and cardiometabolic health specifically targets high-value medical sectors where biometric data is critical for long-term management. The deal ensures Oura controls the software and the medical expertise required to interpret the data its rings collect.
The acquisition represents a significant shift for Oura as it transitions from data collection toward active medical intervention. According to The Verge, Counsel Health operates as an AI-native primary care provider that uses biometric data from wearables to generate medical insights. These AI-driven responses serve as the initial point of contact for users, who can then transition to live consultations with a team of in-house physicians. This integration aims to bridge the gap between continuous health monitoring and professional clinical advice.
Oura intends to utilize this new infrastructure to address three specific health domains. As The Verge reports, the strategy focuses on preventative wellness, acute episodic care, and specialized management for chronic conditions like reproductive and cardiometabolic health. By linking biometric sensors with clinical AI, the company plans to provide more actionable answers to medical questions and offer better monitoring for ongoing health issues. This infrastructure will be supported by Counsel Health's existing team of 70 employees who are set to join Oura's workforce.
Leadership changes are also part of the deal, with Counsel Health CEO Muthu Alagappan slated to become the chief clinical AI officer at Oura. According to The Verge, Alagappan is planning to grow the startup's current network of approximately 50 on-demand doctors. This expansion is designed to meet the growing needs of Oura's user base while maintaining the platform's ability to serve external partners. Oura expects the transaction to be finalized before the conclusion of the current year.
Despite the acquisition, Counsel Health will maintain its presence in the broader healthcare market. The Verge reports that the startup will continue to offer its medical AI platform to external entities including health systems, insurance plans, and various employers. This dual approach allows Oura to own a core piece of clinical technology while Counsel Health continues to generate revenue from enterprise partners and consumer health organizations outside the Oura ecosystem.
The Industry Pulse Bottom Line
Oura's 625 million dollar deal transforms the wearable from a passive tracker into a gateway for professional medical consultation, positioning clinical AI as the necessary bridge between data and diagnosis.